04 feb: Få mere i rente med udbyttebetalende aktier
07 feb: PFA ikke aktionær i Amagerbanken
04-02-2011 18:09:00

Ultralife Corporation to Report Fourth Quarter Results on February 17, 2011

Relateret indhold

Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter and

full year results for the period ended December 31, 2010 before the

market opens on Thursday, February 17, 2011. Ultralife’s management will

host an investor conference call at 10:00 AM ET also on February 17,

2011. Investors are invited to access a live webcast of the conference

call in the Investor Info – Event Calendar section of the company’s

website: http://investor.ultralifecorp.com.

A replay of the webcast will be available shortly after the call at the

same location.

To participate, please call (800) 915-4836, identify yourself and ask

for the Ultralife Call.

About Ultralife Corporation

Ultralife Corporation, which began as a battery company, serves its

markets with products and services ranging from portable and standby

power solutions to communications and electronics systems. Through its

engineering and collaborative approach to problem solving, Ultralife

serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the company's business segments

include: Battery & Energy Products, Communications Systems and Energy

Services. Ultralife has operations in North America, Europe and Asia.

For more information, visit http://www.ultralifecorp.com.

Ultralife Corporation

Philip Fain,

315-332-7100

pfain@ulbi.com

or

Investor

Relations:

Lippert/Heilshorn &

Associates, Inc.

Jody Burfening, 212-838-3777

jburfening@lhai.com

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Rovsing mindsker driftsunderskud i første halvår og opjusterer

24-02-2017 16:36:15
Omsætningen i Rovsing, der har hovedkontor i Skovlunde ved København og blandt andet producerer testsystemer til satellitter og elektroniske produkter til rumin..

KORR. Genmab/Sydbank: Positiv anbefaling er godt nyt - og ventet

24-02-2017 14:04:12
(Korr: "uger" rettet til "måneder" i sjette afsnit)Det europæiske lægemiddelagenturs (EMA) komite for medicinske produkter for human anvendelse (CHMP) har givet..

Aktier/middag: Mærsk og Genmab i C20-bunden og dukkert til Rockwool

24-02-2017 11:44:51
Trods yderligere fremgang til ISS, der torsdag leverede et stærkt regnskab, ligger det danske aktiemarked fredag middag i et minus efter fald i aktier som Mærsk..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Ultralife Corporation 5,50 1,9% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
26. februar 2017 08:51:58
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170217.2 - EUROWEB1 - 2017-02-26 08:51:58 - 2017-02-26 08:51:58 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x